| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0006 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |